|Oral solid doses constitute approximately 60% of drug products. Oral solid dose manufacturing must deal with challenges associated with powder rheology; this is problematic for micronized powders which are cohesive. Poorly water-soluble compounds constitute 40% of currently marketed compounds. Particle size reduction is used to improve drug bioavailability, but causes rheological problems in manufacturing. The lack of constitutive equations leads to a demand for an effective precision dosing process.
Researchers at Purdue University have developed a new micron-scale powder process. This process enables accuracy dosing of drug mass and low product relative standard deviation; additionally, the method allows for specification of particle size distribution in a product by choice of source material, as experiments have demonstrated that particle size is preserved through the printing process.
-Versatile processing of fine particles
-Low relative standard deviation
-Enables production of high-dose pharmaceuticals
|(No issued patents found)|
Purdue Office of Technology Commercialization
The Convergence Center
101 Foundry Drive, Suite 2500
West Lafayette, IN 47906
Phone: (765) 588-3475
Fax: (765) 463-3486